Blinatumomab is FDA approved medication as a second line treatment for Acute Lymphoblastic Leukemia or ALL. More specifically, Blincyto is recommended for Ph- Negative replaced ALL. A specialized drug with superior clinical benefits, Blinatumomab is recommended both in pediatric and adult cases. This drug was originally developed by Micromet. Right now it is available as Blincyto 38.5mcg, promoted by Amgen worldwide. Blinatumomab price for the entire therapy has always been a point of discussion. Blincyto price reduction would bring more patients into the ambit of affordability in the future.
Blincyto 38.5mcg – Approval status by the US FDA and EU EMA
Amgen has been very effective in their pursuit with Blinatumomab clinical trials after acquiring Micromet. Considering the classification of ALL as one of the rare leukemia types, an accelerated approval by both FDA and EMA helped many patients with early access to Blincyto. It has also attained breakthrough drug status by the FDA.
- Blincyto is also an immunotherapy agent to offer overall survival benefit as a single agent, confirming its efficacy in multicenter clinical trials. By even almost doubling the median overall survival, this drug has become a preferred option for Hematologists treating patients with ALL.
- Patients with persistent MRD who are also eligible for BMT/HSCT or Bone Marrow Transplantation can be treated with Blinatumomab. The ongoing clinical research has positive evidence to indicate better outcomes in terms of overall survival.
Blinatumomab in India – Relevant information in terms of cost and access
Blincyto in India is recommended by Hematologist and BMT experts, even though it is yet to be formally approved by the domestic agencies. Patients looking for Blinatumomab price in India may not find relevant information from the local dealers or pharmacies. It is natural for them to search for Blincyto price and they may end up visiting many irrelevant websites. The best solution for patients is to always interact with their treating physicians. Patients who already procured this drug will be of great help in terms of their confident references.
Specialty lifesaving medicines like Blinatumomab in India (Blincyto) would require special patient level licenses to formally import as per the treatment planning. The cost in the international market will be applicable for Indian patients too. Based on the experience of patients who used this drug in the past, the cost varies depending on factors like currency conversion and global supply chain. Blinatumomab price also varies from one country to another and therefore patients are advised to choose their country of import accordingly.
Souring Blinatumomab in India with professional assistance
Blincyto is a cold chain product that needs to be stored and transported in constant 2 to 8 Degree temperature conditions. The effectiveness of this drug can be compromised if not stored and shipped as per the manufacturer’s specifications. CDSCO provides the right platform for Indian patients to legally procure Import Permit for personal use of medicines unavailable in India. By engaging experts who are experienced in patient services pertaining to import medicines, patients can access authentic sources for Blincyto in India. It is also wise to procure the entire lot of medicines as per the dosage recommendations in order to optimize spending on shipping and logistics expenses.
Contact Noel Biotech – +91 9677010046 / +91 992977766; email@example.com